CDC Awards $22,800,000 To Increase Colorectal Cancer Screening

CDC Awards $22,800,000 To Increase Colorectal Cancer Screening

ArticlePress release
Health & Wellness
Diseases & Conditions
Contributed byLester Fahrner, MDApr 10, 2020

CDC awards $22,800,000 to increase colorectal cancer screening

The Centers for Disease Control and Prevention announced today it has awarded a total of $22,800,000 to 24 state health departments, as well as six universities, and one American Indian tribe to increase colorectal screening. The grants, awarded in a competitive process, are designed to increase colorectal (colon) cancer screening rates among men and women aged 50 to 75 years.

“Colorectal cancer is the second leading cancer killer of both men and women in the United States, but most colorectal cancer can be prevented,” said Tom Frieden, M.D., M.P.H., director of the Centers for Disease Control and Prevention. “Screening saves lives and funds we are providing the states will support doctors, nurses, and others to save lives.”

Colorectal cancer screening can find precancerous polyps—abnormal growths in the colon or rectum—so they can be removed before turning into cancer. Screening also helps reduce deaths due to colorectal cancer.

The grantees receiving the awards are:

Alabama State Department of Health

Arkansas Department of Health

California Department of Public Health

Colorado Dept. of Public Health and Environment

Delaware Department of Health and Social Services

District of Columbia Department of Health

Florida Department of Health

Great Plains Tribal Chairmen’s Health Board

Idaho Department of Health and Welfare

Iowa Department of Public Health

Kentucky Cabinet for Health and Family Services

Louisiana State University Health Sciences Center

Maine Department of Health and Human Services

Mary Hitchcock Memorial Hospital (NH)

Maryland Department of Health and Mental Hygiene

Massachusetts Department of Public Health

Michigan Department of Community Health

Minnesota Department of Health

Montana Dept. of Public Health & Human Services

Nevada Division of Public and Behavioral Health

New York State Department of Health

Oregon Health Authority

Rhode Island Department of Health

South Dakota Department of Health

University of Chicago

University of Puerto Rico

University of South Carolina

University of Wisconsin

Virginia Department of Health

Washington State Department of Health

West Virginia University


“We are enthusiastic about these grantees promoting more colorectal cancer screening,” said Lisa Richardson, M.D., M.P.H., director of CDC’s Division of Cancer Prevention and Control. “We know that colorectal cancer screening can prevent illness and death from colorectal cancer. The more people that are screened, the fewer cases of this cancer we’ll see in the future.”

The U.S. Preventive Services Task Force recommends colorectal cancer screening for men and women aged 50–75 using high-sensitivity fecal occult blood testing (FOBT), sigmoidoscopy, or colonoscopy. CDC is requiring all grantee Colorectal Cancer Control Programs (CRCCP) to work with health systems partners to use a combination of evidence-based strategies to increase the number of people screened. These evidence-based strategies include patient and provider reminders, provider assessment and feedback as recommended by the Task Force on Community Preventive Services. They will implement these strategies considering the unique needs and situations of their health systems partners.

Each grantee must target their services towards the following:

Adults 50-75 years of age without symptoms;

Low-income, under- or uninsured, racial and ethnic groups disproportionately affected and/or with geographic barriers to screening;

 At-risk populations.

Moreover, six of the 31 grantees have been awarded additional funds to provide direct colorectal cancer screening and follow-up services to people who meet specific criteria:

Moreover, six of the 31 grantees have been awarded additional funds to provide direct colorectal cancer screening and follow-up services to people who meet specific criteria:

Delaware Department of Health and Social Services

Michigan Department of Community Health

Minnesota Department of Health

Nevada Division of Public and Behavioral Health

New York State Department of Health

Washington State Department of Health


Since the program’s inception in 2009, CRCCP has provided almost 55,000 colorectal cancer screening exams and diagnosed 165 colorectal cancers and 8,441 cases of precancerous polyps. In program year 2014, CRCCP screened 13,425 people for colorectal cancer.

For more information about CDC’s Colorectal Cancer Control Program, visit https://www.cdc.gov/cancer/crccp/.

###

U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES

Was this article helpful

On the Article

Lester Fahrner, MD picture
Approved by

Lester Fahrner, MD

Chief Medical Officer, DoveMed Team

0 Comments

Please log in to post a comment.

Related Articles

Test Your Knowledge

Asked by users

Related Centers

Loading

Related Specialties

Loading card

Related Physicians

Related Procedures

Related Resources

Join DoveHubs

and connect with fellow professionals

Related Directories

Who we are

At DoveMed, our utmost priority is your well-being. We are an online medical resource dedicated to providing you with accurate and up-to-date information on a wide range of medical topics. But we're more than just an information hub - we genuinely care about your health journey. That's why we offer a variety of products tailored for both healthcare consumers and professionals, because we believe in empowering everyone involved in the care process.
Our mission is to create a user-friendly healthcare technology portal that helps you make better decisions about your overall health and well-being. We understand that navigating the complexities of healthcare can be overwhelming, so we strive to be a reliable and compassionate companion on your path to wellness.
As an impartial and trusted online resource, we connect healthcare seekers, physicians, and hospitals in a marketplace that promotes a higher quality, easy-to-use healthcare experience. You can trust that our content is unbiased and impartial, as it is trusted by physicians, researchers, and university professors around the globe. Importantly, we are not influenced or owned by any pharmaceutical, medical, or media companies. At DoveMed, we are a group of passionate individuals who deeply care about improving health and wellness for people everywhere. Your well-being is at the heart of everything we do.

© 2023 DoveMed. All rights reserved. It is not the intention of DoveMed to provide specific medical advice. DoveMed urges its users to consult a qualified healthcare professional for diagnosis and answers to their personal medical questions. Always call 911 (or your local emergency number) if you have a medical emergency!